Earnest Partners LLC Becton Dickinson & CO Transaction History

Earnest Partners LLC

$22.1 Billion
Q3 2024

A detailed history of Earnest Partners LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Earnest Partners LLC holds 6,140 shares of BDX stock, worth $1.36 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,140

Previous 6,227 1.4%

Holding current value

$1.36 Million

Previous $1.46 Million 1.72%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$221.47 - $242.41 $19,267 - $21,089	-87 Reduced 1.4%	6,140 $1.48 Million
Q2 2024 Aug 14, 2024	SELL	$225.07 - $246.17 $47,714 - $52,188	-212 Reduced 3.29%	6,227 $1.46 Million
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $20,543 - $21,800	-88 Reduced 1.35%	6,439 $1.59 Million
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $1.29 Million - $1.49 Million	-5,563 Reduced 46.01%	6,527 $1.59 Million
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $765,974 - $852,187	3,005 Added 33.08%	12,090 $3.13 Million
Q2 2023 Aug 07, 2023	SELL	$238.39 - $265.32 $159,482 - $177,499	-669 Reduced 6.86%	9,085 $2.4 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $273,735 - $322,165	1,254 Added 14.75%	9,754 $2.48 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $6,480 - $33,557	127 Added 1.52%	8,500 $1.89 Million
Q2 2022 Aug 12, 2022	SELL	$234.74 - $275.42 $102,346 - $120,083	-436 Reduced 4.95%	8,373 $2.06 Million
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $622,987 - $691,617	2,557 Added 40.9%	8,809 $2.34 Million
Q4 2021 Feb 07, 2022	SELL	$230.08 - $250.94 $63,041 - $68,757	-274 Reduced 4.2%	6,252 $1.57 Million
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $128,228 - $141,314	-551 Reduced 7.79%	6,526 $1.6 Million
Q2 2021 Aug 16, 2021	SELL	$232.65 - $254.58 $85,615 - $93,685	-368 Reduced 4.94%	7,077 $1.72 Million
Q1 2021 May 17, 2021	SELL	$232.09 - $256.88 $268,992 - $297,723	-1,159 Reduced 13.47%	7,445 $1.81 Million
Q4 2020 Feb 16, 2021	SELL	$221.92 - $245.94 $4.29 Million - $4.76 Million	-19,335 Reduced 69.2%	8,604 $2.15 Million
Q3 2020 Nov 16, 2020	SELL	$215.77 - $276.76 $218,790 - $280,634	-1,014 Reduced 3.5%	27,939 $6.5 Million
Q2 2020 Aug 13, 2020	SELL	$219.9 - $263.41 $8.9 Million - $10.7 Million	-40,489 Reduced 58.31%	28,953 $6.93 Million
Q1 2020 May 14, 2020	SELL	$195.69 - $279.01 $1.69 Million - $2.41 Million	-8,632 Reduced 11.06%	69,442 $16 Million
Q4 2019 Feb 07, 2020	SELL	$236.45 - $266.82 $427,265 - $482,143	-1,807 Reduced 2.26%	78,074 $21.2 Million
Q3 2019 Nov 14, 2019	SELL	$230.58 - $256.08 $1.04 Million - $1.16 Million	-4,526 Reduced 5.36%	79,881 $20.2 Million
Q2 2019 Aug 13, 2019	SELL	$217.4 - $246.08 $796,988 - $902,129	-3,666 Reduced 4.16%	84,407 $21.3 Million
Q1 2019 May 15, 2019	BUY	$206.05 - $248.17 $70,469 - $84,874	342 Added 0.39%	88,073 $22 Million
Q4 2018 Feb 14, 2019	SELL	$204.73 - $257.93 $39,717 - $50,038	-194 Reduced 0.22%	87,731 $19.8 Million
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $363,822 - $399,616	-1,561 Reduced 1.74%	87,925 $22.9 Million
Q2 2018 Aug 13, 2018	SELL	$208.1 - $233.85 $16,439 - $18,474	-79 Reduced 0.09%	89,486 $21.4 Million
Q1 2018 May 15, 2018	SELL	$205.46 - $240.27 $6.99 Million - $8.17 Million	-34,019 Reduced 27.53%	89,565 $19.4 Million
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $10.6 Million - $12.5 Million	56,320 Added 83.73%	123,584 $26.5 Million
Q3 2017 Nov 14, 2017	SELL	$186.89 - $198.9 $386,301 - $411,126	-2,067 Reduced 2.98%	67,264 $13.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	69,331	69,331 $13.5 Million

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Earnest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Earnest Partners LLC with notifications on news.

Account

Earnest Partners LLC Becton Dickinson & CO Transaction History